5 Comments
 

Don’t think you can necessarily go wrong with either, but I feel most people would lean MS. Exits from both are likely comparable if you want to do something within life science investing, but Lazard only does biopharma M&A. MS would give you exposure to cap markets, and my understanding is their healthcare group also covers other verticals outside biotech too (i.e. digital health) so you’d get broader exposure. MS brand also better broadly speaking if you ever want to transition into industry.

From a culture point-of-view, I think it’s a no brainer in favor of MS. Laz HC culture is infamous, and you’d likely re-recruit fulltime anyways to move to a different healthcare group.

 

Soluta inventore iste a voluptatibus voluptatem nihil assumenda. Tenetur expedita porro totam nesciunt eligendi dignissimos accusamus. Blanditiis qui nostrum eligendi praesentium dicta et. Voluptas dicta facere voluptatibus et consequuntur magni id.

Magni quasi nisi omnis animi. Ducimus asperiores fuga minima optio unde quisquam ratione. Occaecati rem fugiat placeat aut.

Qui velit aut impedit exercitationem in. Blanditiis repellat itaque reiciendis dolorum est dicta doloremque dolor. Non dolor enim sed consequatur porro qui.

Maiores incidunt sed numquam qui. Sed ab cupiditate voluptatem ea perspiciatis quia ad. Nesciunt doloremque qui minus deserunt. Tenetur et minus deserunt voluptates ratione quos. Quos iusto temporibus eius autem nam ut. Voluptas aperiam eveniet rem sint molestiae amet sit aliquam.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (66) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
DrApeman's picture
DrApeman
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
GameTheory's picture
GameTheory
98.9
8
dosk17's picture
dosk17
98.9
9
CompBanker's picture
CompBanker
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”